Cargando…
Remote-controlled cholangiography injection device: first clinical study in China
BACKGROUND: X-ray cholangiography is of great value in the imaging of biliary tract diseases; however, occupational radiation exposure is unavoidable. Moreover, clinicians must manually inject the contrast dye, which may result in a relatively high incidence of adverse reactions due to unstable inje...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742431/ https://www.ncbi.nlm.nih.gov/pubmed/34996384 http://dx.doi.org/10.1186/s12876-021-02087-8 |
_version_ | 1784629711680307200 |
---|---|
author | Chen, Huan Shan, Li-yu Ma, Tao Wang, Yue Feng, Zhe Dong, Ding-Hui Lv, Yi Zhu, Hao-Yang |
author_facet | Chen, Huan Shan, Li-yu Ma, Tao Wang, Yue Feng, Zhe Dong, Ding-Hui Lv, Yi Zhu, Hao-Yang |
author_sort | Chen, Huan |
collection | PubMed |
description | BACKGROUND: X-ray cholangiography is of great value in the imaging of biliary tract diseases; however, occupational radiation exposure is unavoidable. Moreover, clinicians must manually inject the contrast dye, which may result in a relatively high incidence of adverse reactions due to unstable injection pressure. Thus, there is a need to develop a novel remote-controlled cholangiography injection device. METHODS: Patients with external biliary drainage requiring cholangiography were included. A remote-controlled injection device was developed with three major components: an injection pump, a pressure sensor, and a wireless remote-control panel. Image quality, adverse reactions, and radiation dose were evaluated. RESULTS: Different kinds of X-ray cholangiography were successfully and smoothly performed using this remote-controlled injection device in all patients. The incidence of adverse reactions in the device group was significantly lower than that in the manual group (4.17% vs. 13.9%, P = 0.001), and increasing the injection pressure increased the incidence of adverse reactions. In addition, the device helped operators avoid ionizing radiation completely. CONCLUSIONS: With good control of injection pressure (within 10 kPa), the remote-controlled cholangiography injection device could replace the need for the doctor to inject contrast agent with good security and effectivity. It is expected to be submitted for clinical application. |
format | Online Article Text |
id | pubmed-8742431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87424312022-01-10 Remote-controlled cholangiography injection device: first clinical study in China Chen, Huan Shan, Li-yu Ma, Tao Wang, Yue Feng, Zhe Dong, Ding-Hui Lv, Yi Zhu, Hao-Yang BMC Gastroenterol Research BACKGROUND: X-ray cholangiography is of great value in the imaging of biliary tract diseases; however, occupational radiation exposure is unavoidable. Moreover, clinicians must manually inject the contrast dye, which may result in a relatively high incidence of adverse reactions due to unstable injection pressure. Thus, there is a need to develop a novel remote-controlled cholangiography injection device. METHODS: Patients with external biliary drainage requiring cholangiography were included. A remote-controlled injection device was developed with three major components: an injection pump, a pressure sensor, and a wireless remote-control panel. Image quality, adverse reactions, and radiation dose were evaluated. RESULTS: Different kinds of X-ray cholangiography were successfully and smoothly performed using this remote-controlled injection device in all patients. The incidence of adverse reactions in the device group was significantly lower than that in the manual group (4.17% vs. 13.9%, P = 0.001), and increasing the injection pressure increased the incidence of adverse reactions. In addition, the device helped operators avoid ionizing radiation completely. CONCLUSIONS: With good control of injection pressure (within 10 kPa), the remote-controlled cholangiography injection device could replace the need for the doctor to inject contrast agent with good security and effectivity. It is expected to be submitted for clinical application. BioMed Central 2022-01-07 /pmc/articles/PMC8742431/ /pubmed/34996384 http://dx.doi.org/10.1186/s12876-021-02087-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chen, Huan Shan, Li-yu Ma, Tao Wang, Yue Feng, Zhe Dong, Ding-Hui Lv, Yi Zhu, Hao-Yang Remote-controlled cholangiography injection device: first clinical study in China |
title | Remote-controlled cholangiography injection device: first clinical study in China |
title_full | Remote-controlled cholangiography injection device: first clinical study in China |
title_fullStr | Remote-controlled cholangiography injection device: first clinical study in China |
title_full_unstemmed | Remote-controlled cholangiography injection device: first clinical study in China |
title_short | Remote-controlled cholangiography injection device: first clinical study in China |
title_sort | remote-controlled cholangiography injection device: first clinical study in china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742431/ https://www.ncbi.nlm.nih.gov/pubmed/34996384 http://dx.doi.org/10.1186/s12876-021-02087-8 |
work_keys_str_mv | AT chenhuan remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina AT shanliyu remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina AT matao remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina AT wangyue remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina AT fengzhe remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina AT dongdinghui remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina AT lvyi remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina AT zhuhaoyang remotecontrolledcholangiographyinjectiondevicefirstclinicalstudyinchina |